2268 — WuXi XDC Cayman Share Price
Last trade - 00:00- HK$22.39bn
- HK$18.01bn
- CNY2.12bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 30.33 | ||
| PEG Ratio (f) | 0.7 | ||
| EPS Growth (f) | 75.97% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.79 | ||
| Price to Tang. Book | 3.99 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 9.73 | ||
| EV to EBITDA | 39.62 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.6% | ||
| Return on Equity | 8.18% | ||
| Operating Margin | 16.97% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | 96.35 | 311.13 | 990.42 | 2,123.84 | 3,130.84 | 4,567.87 | 180.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +108.51 | +183.86 | +98.33 | +89.33 | +58.27 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
WuXi XDC Cayman Inc is a holding company primarily engaged in the provision of contract research, development and manufacturing services (CRDMO) for antibody drug conjugates (ADCs) and a wider range of bioconjugate drugs. The Company conducts its businesses through two segments. Research Services on Fee-for-service(FFS) Basis segment providing research services to its customers through FFS contracts. The Research Services on Full-time-equivalent(FTE) Basis segment providing a project team of employees dedicated to the customer's studies for a specific period of time. Based on biopharmaceuticals and small molecule drugs, the Company also provides comprehensive cross-domain services, covering the discovery, process development and good manufacturing practice (GMP) production of bioconjugated drugs, linkers and payloads. The Company conducts its business in domestic and foreign markets.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 14th, 2020
- Public Since
- November 17th, 2023
- No. of Employees
- 1,178
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,178,446,000
- Address
- No. 11 Xinhui Ring Road, Xinwu District, WUXI, KY1-1104
- Web
- https://wuxixdc.com/
- Phone
- Contact
- Chris Fang
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 2268
Similar to 2268
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:24 UTC, shares in WuXi XDC Cayman are trading at HK$19.00. This share price information is delayed by 15 minutes.
Shares in WuXi XDC Cayman last closed at HK$19.00 and the price had moved by over the past 365 days. In terms of relative price strength the WuXi XDC Cayman share price has matched the FTSE Developed Asia Pacific Index by over the past year.
The overall consensus recommendation for WuXi XDC Cayman is Buy. You can view the full broker recommendation list by unlocking its StockReport.
WuXi XDC Cayman does not currently pay a dividend.
WuXi XDC Cayman does not currently pay a dividend.
WuXi XDC Cayman does not currently pay a dividend.
To buy shares in WuXi XDC Cayman you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$19.00, shares in WuXi XDC Cayman had a market capitalisation of HK$22.39bn.
Here are the trading details for WuXi XDC Cayman:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2268
Based on an overall assessment of its quality, value and momentum WuXi XDC Cayman is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in WuXi XDC Cayman is HK$30.58. That is 60.93% above the last closing price of HK$19.00.
Analysts covering WuXi XDC Cayman currently have a consensus Earnings Per Share (EPS) forecast of CNY0.50 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like WuXi XDC Cayman. Over the past six months, its share price has matched the FTSE Developed Asia Pacific Index by .
As of the last closing price of HK$19.00, shares in WuXi XDC Cayman were trading -21.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The WuXi XDC Cayman PE ratio based on its reported earnings over the past 12 months is 30.33. The shares last closed at HK$19.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on WuXi XDC Cayman's directors